- Trials with a EudraCT protocol (73)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3,341)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: Boccazzi A, Tonelli P, Bellosta C, Careddu P. Clinical and pharmacological evaluation of a modified cefotaxime bid regimen versus traditional tid in pediatric lower respiratory tract infections. Diagn Microbiol Infect Dis. 1998 Dec;32(4):265-72.Boccazzi A, Tonelli P, Bellosta C, Careddu P. Clinical and pharmacological evaluation of a modified cefotaxime bid regimen versus traditional tid in pediatric lower respiratory tract infections. Diagn Microbiol Infect Dis. 1998 Dec;32(4):265-72. |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23464 |
| Study title: Clinical Expert Report + complement to the Clinical Expert Report, Clinical studies - summaries & synopses - C.Safran - 1992Clinical Expert Report + complement to the Clinical Expert Report, Clinical studies - summaries & synopses - C.Safran - 1992 |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23544 |
| Study title: Comparative trial of the efficacy and tolerance of oral RU 51807 (cefpodoxime proxetil) and AUGMENTIN (co-amoxiclav) in the treatment of acute infections of the ear, nose and throat in children |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): CEFPODOXIME STUDY UK9080705.xls |
| View full study record |
| Document reference: 47966 |
| Study title: Comparison of cefpodoxime proxetil oral suspension (100 mg / 5 ml) (DoxefTM; U-76252; CS-807) and penicillin V potassium oral suspension in the treatment of acute streptococcal pharyngitis / tonsillitis in infants and children - M-1140-0028 - LM. Paxton |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): CEFPODOXIME STUDY TR915590018.xls |
| View full study record |
| Document reference: 23523 |
| Study title: Comparison of Cefpodoxime Proxetil Oral Suspension (100mg/5ml) (DOXEF; U-76.252; CS-807) vs amoxicillin/clavulanate potassium (Augmentin) Oral Suspension (250mg/5ml) in the Treatment of acute suppurative otitis media in infants and children |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): CEFPODOXIME STUDY TR915590037.xls |
| View full study record |
| Document reference: 47967 |
| Study title: Comparison of Cefpodoxime Proxetil Oral Suspension vs Trimethoprim/Sulfamethoxazole Oral Suspension in the Treatment of Uncomplicated Urinary Tract Infections |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): CEFPODOXIME STUDY TR915590001.xls |
| View full study record |
| Document reference: 47969 |
| Study title: Concentrations of cefpodoxime (RU 51763) in plasma and middle ear effusion after repeated doses (3 doses) of cefpodoxime proxetil - Pr. P. Begue, Pr. EN. Garabedian - 1991 (Ref: FFR 89 / 807 / 03) |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): CEFPODOXIME STUDY FFR8980703.xls |
| View full study record |
| Document reference: 23524 |
| Study title: Etude comparative du cefixime per os versus ceftriaxone parenterale, en relais d'une bi-antibiotherapie intraveineuse associant ceftriaxone et netilmicine, dans le traitement des pyelonephrites aigues des enfants de plus de 6 mois - Patrice François - mai 1996 |
| Active substance: CEFIXIME |
| Study summary document link (including results): Cefixime STUDY 392004.xls |
| View full study record |
| Document reference: 23376 |
| Study title: Oberlin O et al, Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology, J Clin Oncol. 1992 Oct;10(10):1602-8Oberlin O et al, Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology, J Clin Oncol. 1992 Oct;10(10):1602-8 |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22773 |
| Study title: Other or AllOther or All |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22798 |
| Study title: Pediatr Blood Cancer. 2004 Mar;42(3):210-5Pediatr Blood Cancer. 2004 Mar;42(3):210-5 |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22815 |
| Study title: Pinkerton CR et al, 'JEB'--a carboplatin based regimen for malignant germ cell tumours in children, Br J Cancer. 1990 Aug;62(2):257-62, Pinkerton CR et al, 'JEB'--a carboplatin based regimen for malignant germ cell tumours in children, Br J Cancer. 1990 Aug;62(2):257-62, |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22809 |
| Study title: Pinkerton CR et al, High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy, J Clin Oncol. 1986 Feb;4(2):194-9, Pinkerton CR et al, High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy, J Clin Oncol. 1986 Feb;4(2):194-9, |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22810 |
| Study title: Pinkerton CR et al, Response rates in relapsed Wilms' tumor. A need for new effective agents, Cancer. 1991 Feb 1;67(3):567-71Pinkerton CR et al, Response rates in relapsed Wilms' tumor. A need for new effective agents, Cancer. 1991 Feb 1;67(3):567-71 |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22829 |
| Study title: Popadiuk S et al, Testicular malignant tumours. Efficacy of germ cell and sex cord tumours, treatment protocol in Poland, Med Wieku Rozwoj. 2006 Jul-Sep;10(3 Pt 1):811-7. PolishPopadiuk S et al, Testicular malignant tumours. Efficacy of germ cell and sex cord tumours, treatment protocol in Poland, Med Wieku Rozwoj. 2006 Jul-Sep;10(3 Pt 1):811-7. Polish |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22760 |
| Study title: Provisor AJ et al, Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group, J Clin Oncol. 1997 Jan;15(1):76-84Provisor AJ et al, Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group, J Clin Oncol. 1997 Jan;15(1):76-84 |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22833 |
| Study title: Rogers PC et al, Treatment of children and adolescents with stage II testicular and stages I and, II ovarian malignant germ cell tumors: A Pediatric Intergroup Study—Pediatric Oncology Group 9048 and Children's Cancer Group 8891, J Clin Oncol. 2004 Sep 1;22(17):3563-9, Rogers PC et al, Treatment of children and adolescents with stage II testicular and stages I and, II ovarian malignant germ cell tumors: A Pediatric Intergroup Study—Pediatric Oncology Group 9048 and Children's Cancer Group 8891, J Clin Oncol. 2004 Sep 1;22(17):3563-9, |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22802 |
| Study title: Safety LungSafety Lung |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22816 |
| Study title: Safety Other MultipleSafety Other Multiple |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22823 |
| Study title: Bristish Thoracic Society Guidelines for the management of Community Acquired Pneumonia in Childhood. Thorax 2002, 57 Suppl;1-24Bristish Thoracic Society Guidelines for the management of Community Acquired Pneumonia in Childhood. Thorax 2002, 57 Suppl;1-24 |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23465 |
| Study title: Cefotaxime CES Final 2.1 - Agnès A. Bouvet, MD, 06/09/04Cefotaxime CES Final 2.1 - Agnès A. Bouvet, MD, 06/09/04 |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23466 |
| Study title: Cefotaxime in the treatment of Staphylococcal infections:comparison of in vitro and in vivo studies, Kenneth E. Aldridge, Diagn. Microbiol. Infect. Dis., 1995;22:195-201Cefotaxime in the treatment of Staphylococcal infections:comparison of in vitro and in vivo studies, Kenneth E. Aldridge, Diagn. Microbiol. Infect. Dis., 1995;22:195-201 |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23467 |
| Study title: Cerebrospinal Fluid Bactericidal Activity against Cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime, Ian R.Friedland, Keith Klugman, Antimicrobial Agents and Chemotherapy, Sep 1997, p. 1888-18Cerebrospinal Fluid Bactericidal Activity against Cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime, Ian R.Friedland, Keith Klugman, Antimicrobial Agents and Chemotherapy, Sep 1997, p. 1888-18 |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23468 |
| Study title: Cerebrospinal Fluid Bactericidal Activity against Cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime, Ian R.Friedland, Keith Klugman, Antimicrobial Agents and Chemotherapy, Sep 1997, p. 1888-1891.Cerebrospinal Fluid Bactericidal Activity against Cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime, Ian R.Friedland, Keith Klugman, Antimicrobial Agents and Chemotherapy, Sep 1997, p. 1888-1891. |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23469 |
| Study title: Clinical and Pharmacological Evaluation of modified cefotaxime bid regimen Vs traditional tid in pediatric lower respiratory tract infections, A.Boccazzi, P.Tonelli, C.Bellosta, P.Careddu, Diagn Microbiol Infect Dis 1998;32:265-272Clinical and Pharmacological Evaluation of modified cefotaxime bid regimen Vs traditional tid in pediatric lower respiratory tract infections, A.Boccazzi, P.Tonelli, C.Bellosta, P.Careddu, Diagn Microbiol Infect Dis 1998;32:265-272 |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23470 |
| Study title: Clinical study report N° FR/94/756/12 : open label, non-comparative study of cefotaxime (300 mg / kg / day) plus vancomycin (60 mg / kg / day) combination as first line treatment of pneumococcal meningitis in children aged from 3 months to 18 years - HoecClinical study report N° FR/94/756/12 : open label, non-comparative study of cefotaxime (300 mg / kg / day) plus vancomycin (60 mg / kg / day) combination as first line treatment of pneumococcal meningitis in children aged from 3 months to 18 years - Hoec |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23471 |
| Study title: Comparison of Ceftriaxone versus Cefotaxime for childhood Upper Urinary Tract Infections, A.Bakkaloglu, U.Saatci, O.Soylemezoglu, S.Ozen, R.Topaloglu, N.Besbas, I.Saatci, Jouranl of Chemotherapy, Vol.8, n.1 (59-62) - 1996Comparison of Ceftriaxone versus Cefotaxime for childhood Upper Urinary Tract Infections, A.Bakkaloglu, U.Saatci, O.Soylemezoglu, S.Ozen, R.Topaloglu, N.Besbas, I.Saatci, Jouranl of Chemotherapy, Vol.8, n.1 (59-62) - 1996 |
| Active substance: CEFOTAXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23472 |
| Study title: Sarcoma EwingsSarcoma Ewings |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22825 |
| Study title: Sarcoma NephroblastomaSarcoma Nephroblastoma |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22828 |
| Study title: Sarcoma OsteosarcomaSarcoma Osteosarcoma |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22830 |
| Study title: Sarcoma RhabdomyosarcomaSarcoma Rhabdomyosarcoma |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22842 |
| Study title: Schellong G et al, Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group, J Clin Oncol. 2005 Sep 1;23(25):6181-9Schellong G et al, Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group, J Clin Oncol. 2005 Sep 1;23(25):6181-9 |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22764 |
| Study title: Schmidt P et al, Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update, Klin Padiatr. 2002 Jul-Aug;214(4):167-72. GermanSchmidt P et al, Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update, Klin Padiatr. 2002 Jul-Aug;214(4):167-72. German |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22758 |
| Study title: Comparative evaluation of cefadroxil and cephalexin in children and adolescents with pyodermas (report for study AI404-034, published in Clinical Therapeutics). |
| Active substance: CEFADROXIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23386 |
| Study title: Demidovitch, Witler Ruff, Bass, Browning: Impetigo: Current etiology and comparison of penicillin, erythromycin and cephalexin therapies. Am J Dis Child 1990 144 1313-1315Demidovitch, Witler Ruff, Bass, Browning: Impetigo: Current etiology and comparison of penicillin, erythromycin and cephalexin therapies. Am J Dis Child 1990 144 1313-1315 |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23539 |
| Study title: Diffusion of cefpodoxime (RU 51763) in the tonsils and adenoids after repeated administrations of cefpodoxime proxetil to children - Pr. Kafetzsis, Pr. P Begue - 1992 (Ref: GR 89 / 807 / 51) |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): CEFPODOXIME STUDY GR8980751.xls |
| View full study record |
| Document reference: 23525 |
| Study title: Dillion, Ware: Sources and susceptibilities of staphyloccoci isolated from children. A seven year survey. Am J. Dis Child 1981 135:417-430Dillion, Ware: Sources and susceptibilities of staphyloccoci isolated from children. A seven year survey. Am J. Dis Child 1981 135:417-430 |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23540 |
| Study title: Effects of cefpodoxime proxetil (CS-807) on intestinal bacterial flora - T. Iwata , K. Yamada - 1989 (Ref: SA/92/03/CL) |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): CEFPODOXIME STUDY SA9203CL.xls |
| View full study record |
| Document reference: 23545 |
| Study title: Effects of new oral cephalosporin cefpodoxime proxetil (RU 51 807) vs Augmentin on intestinal bacterial flora of paediatric patients, randomized, two arm, open label comparative - Dr. P. De Simoni, Dr. L. De Ciano - 1992 -Ref: I 89 / 807 / 11) |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): CEFPODOXIME STUDY I8980711.xls |
| View full study record |
| Document reference: 23526 |
| Study title: Efficacy and safety of cefpodoxime proxetil paediatric formulation in children with upper and lower respiratory tract infections |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): CEFPODOXIME STUDY FD9380793.xls |
| View full study record |
| Document reference: 47970 |
| Study title: Efficacy and tolerance of Cefpodoxime poxetil in children under one year of age - No author - 30/01/1989Efficacy and tolerance of Cefpodoxime poxetil in children under one year of age - No author - 30/01/1989 |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23546 |
| Study title: Esterley, Nelson, Dunne: Impetigo. Am J Dis Child 1991 145 125-126Esterley, Nelson, Dunne: Impetigo. Am J Dis Child 1991 145 125-126 |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23541 |
| Study title: Comparative evaluation of cefadroxil and cephalexin in children and adolescents with pyodermas. |
| Active substance: CEFADROXIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45097 |
| Study title: Randomized, multicenter open study comparing the efficacy of potassium-phenoxymethylpenicillin V three times daily for 10 days versus benzathine penicillin V twice daily for 5 days in the treatment of acute group A ß-hemolytic streptococcal tonsillopharyngitis in children |
| Active substance: CEFALEXIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23388 |
| Study title: Randomized, multicenter pilot study comparing the efficacy of potassium-phenoxymethylpenicillin granules for oral suspension 100.000 IU /kg/day tid for 10 days versus benzathine-phenoxymethylpenicillin suspension 100.000 IU /kg/day bid for 7 days versus benzathine-phenoxymethylpenicillin suspension 100.000 IU /kg/day bid for 5 days in the treatment of acute group A ß-hemolytic streptococcal tonsillopharyngitis in children |
| Active substance: CEFALEXIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23387 |
| Study title: A randomized open - label comparison of cefepime versus ceftazidime in the treatment of severe bacterial infections in children. |
| Active substance: CEFEPIM |
| Study summary document link (including results): Protocol AI411-213 Cefepime.pdf |
| View full study record |
| Document reference: 23397 |
| Study title: A Randomized Open-Label Comparison of Cefepime versus Ceftazidime in the Treatment of Pyelonephritis in Children |
| Active substance: CEFEPIM |
| Study summary document link (including results): Protocol AI411-235 Cefepime.pdf |
| View full study record |
| Document reference: 23396 |
| Study title: Final Report on Protocol AI411-213, A Randomized Open-Label Comparison of Cefepime versus Ceftazidime in the Treatment of Severe Bacterial Infections in Children. |
| Active substance: CEFEPIM |
| Study summary document link (including results): Protocol AI411-213 Cefepime.pdf |
| View full study record |
| Document reference: 23395 |
| Study title: Ongoing Report on Protocol AI411-220, A Multi-Investigator Comparative Study of Cefepime and Cefotaxime in the Treatment of Meningitis: An Interim Report. |
| Active substance: CEFEPIM |
| Study summary document link (including results): Protocol AI411-220 Cefepime.pdf |
| View full study record |
| Document reference: 23390 |
| Study title: Ongoing Report on Protocol AI411-220, A Multi-Investigator Comparative Study of Cefepime and Cefotaxime in the Treatment of Meningitis: An Interim Report. |
| Active substance: CEFEPIM |
| Study summary document link (including results): Protocol AI411-220 Cefepime.pdf |
| View full study record |
| Document reference: 23400 |
| Study title: Report on Protocol AI411-126, A Multi-Investigator Comparative Study of Cefepime and Cefotaxime in the Treatment of Central Nervous System Infections Including Meningitis. |
| Active substance: CEFEPIM |
| Study summary document link (including results): Protocol AI411-126 Cefepime.pdf |
| View full study record |
| Document reference: 23398 |
| Study title: Report on Protocol AI411-129, A Non-Comparative Study of the Safety, Efficacy, and Pharmacokinetics of Cefepime in Pediatric Patients with Serious Bacterial Infections. |
| Active substance: CEFEPIM |
| Study summary document link (including results): Protocol AI411-129 Safety Efficacy Cefepime.pdf |
| View full study record |
| Document reference: 23409 |
| Study title: Report on Protocol AI411-131, A Comparative Study of Cefepime Versus Ceftazidime in the Treatment of Pediatric Cancer Patients with Fever and Neutropenia. |
| Active substance: CEFEPIM |
| Study summary document link (including results): Protocol AI411-131 Cefepime.pdf |
| View full study record |
| Document reference: 23405 |
| Study title: Etude comparative du cefixime per os versus ceftriaxone parenterale, en relais d'une bi-antibiotherapie intraveineuse associant ceftriaxone et netilmicine, dans le traitement des pyelonephrites aigues des enfants de plus de 6 mois - Patrice François - mai 1996 |
| Active substance: CEFIXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23411 |
| Study title: Proceedings: Effect of pre-operative antibiotic regimen on development of infection after intestinal surgery.Nwako F. West African journal of pharmacology and drug research, {West−Afr−J− Pharmacol−Drug−Res}, Jun 1975, vol. 2, no. 1, p. 75P, ISSN: 0303−691X. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26546 |
| Study title: Prophylactic oral antibiotics for low−risk dog bite wounds. Dire DJ, Hogan DE, Walker JS. Pediatric emergency care, Aug 1992, vol. 8, no. 4, p. 194−9. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26477 |
| Study title: Randomised comparison of amoxycillin and erythromycin in treatment of genital chlamydial infection in pregnancy. Alary M, Joly JR, Moutquin JM, Mondor M, Boucher M, Fortier A, Pinault JJ, Paris G, Carrier S, Chamberland H, et al. Lancet, 26 Nov 1994, vol. 344, no. 8935, p. 1461−5. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26464 |
| Study title: Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Bailey RL, Arullendran P, Whittle HC, Mabey DC. Lancet. 1993 Aug 21;342(8869):453-6. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26570 |
| Study title: Randomized trial of prophylactic antibiotic therapy after preterm amnion rupture. Owen J, Groome LJ, Hauth JC. American journal of obstetrics and gynecology, , Oct 1993, vol. 169, no. 4, p.976−81. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26469 |
| Study title: Recurrent attacks of scarlet fever. Chiesa C, Pacifico L, Nanni F, Orefici G. Archives of pediatrics & adolescent medicine, Jun 1994, vol. 148, no. 6, p. 656−60. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26466 |
| Study title: Roxithromycin in the therapy of Streptococcus pyogenes throat infections. Herron J M. The Journal of antimicrobial chemotherapy, {J−Antimicrob−Chemother}, Nov 1987, vol. 20 Suppl B, p. 139−44, ISSN: 0305−7453. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26509 |
| Study title: Safety and efficacy of azithromycin in the treatment of community acquired pneumonia in children. Harris J A, Kolokathis A, Campbell M, Cassell G H, Hammerschlag M R. The Pediatric infectious disease journal, {Pediatr Infect Dis J}, Oct 1998, vol. 17, no. 10, p. 865 71. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26445 |
| Study title: (Salbutamol combined with erythromycin and sobrerol in the therapy of pertussis). Salbutamolo, associato a eritromicina e sobrerolo, nella terapia della pertosse. Crosca V, Ajello A, Crosca C, Minniti A. Archivio per le scienze mediche, {Arch−Sci−Med−Torino}, Apr−Jun 1982, vol. 139, no. 2, p. 247−50 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26535 |
| Study title: [Severe endemic trachoma in Tunisia: changes in ocular bacterial pathogens in children treated by the intermittent antibiotic regimen] Whitcher JP, Dawson CR, Messadi M, Daghfous T, Abdullah NB, Triki F, Hoshiwara I. Rev Int Trach. 1974;51(4):49-58. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26573 |
| Study title: Short−course erythromycin therapy for endocervical chlamydia during pregnancy. Thomason JL, Kellett AV, Gelbart SM, James JA, Broekhuizen FF. The Journal of family practice, Jun 1990, vol. 30, no. 6, p. 711−2. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26492 |
| Study title: Short−course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group. Felstead SJ, Daniel R. The Journal of international medical research, Sep− Oct 1991, vol. 19, no. 5, p.363−72. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26484 |
| Study title: Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group. Daniel R. The Journal of international medical research, Sep− Oct 1991, vol. 19, no. 5, p.373−83. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26483 |
| Study title: Spiramycin and erythromycin in the treatment of acute tonsillo− pharyngitis: a comparative study. Soekrawinata T, Ibrahim T, Driyatno E. Current medical research and opinion, {Curr−Med−Res−Opin}, 1984, vol. 9, no. 5, p. 296−300. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26522 |
| Study title: Streptococcus pneumoniae endophthalmitis: a study of 36 cases with special reference to antibiotic resistance and treatment options.Soriano F, Pérez Trallero E, Pallarés R, Meseguer M A, Fleites A, Gené A, González A, Liñares J, Esteban J, Baquero F, Valdés E, Muñoz Almagro C. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, { Jun 2006, vol. 12, no. 6, p. 519 26 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26416 |
| Study title: Systemic corticosteroid and isotretinoin treatment in cystic acne. Karvonen SL, Vaalasti A, Kautiainen H, Reunala T. Acta dermato−venereologica, Dec 1993, vol. 73, no. 6, p. 452−5. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26468 |
| Study title: Bacci G et al Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies Cancer 1998 Mar 15;82(6):1174-83 |
| Active substance: ETOPOSIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26701 |
| Study title: Bacci G et al Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed afteradding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide,and doxorubicin in the maintenance phase--results of two sequential studies Cancer. 1998 Mar 15;82(6):1174-83 |
| Active substance: ETOPOSIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26780 |
| Study title: Bacci G et al Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patientstreated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin,cyclophosphamide, dactinomycin, ifosfamide and etoposide) Minerva Pediatr. 1995 Nov;47(11):457-69. Italian |
| Active substance: ETOPOSIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26781 |
| Study title: Bagatell R et al, Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy, J Clin Oncol. 2005 Dec 1;23(34):8819-27 |
| Active substance: ETOPOSIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26930 |
| Study title: Cushing B et al, Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study—Pediatric Oncology Group 9049 and Children's Cancer Group 8882, J Clin Oncol. 2004 Jul 1;22(13):2691-700 |
| Active substance: ETOPOSIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26854 |
| Study title: DTPw-HBV-006 |
| Active substance: diphtheria, tetanus, inactivated whole cell pertussis, hepatitis b recombinant, adsorbed vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41611 |
| Study title: Open, controlled, randomized phase III clinical study to assess the immunogenicity and reactogenicity of TdcP-IPV vaccine vs DTacP + OPV in 6 years old children previously immunized with 4 doses of DTwcP and OPV from 2 months of age. |
| Active substance: Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47295 |
| Study title: A comparative study of dirithromycin and erythromycin in bacterial pneumonia.Liippo K, Tala E, Puolijoki H, Brückner OJ, Rodrig J, Smits JP. The Journal of infection, Mar 1994, vol. 28, no. 2, p. 131−9. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26465 |
| Study title: A comparative study of spiramycin and erythromycin in acute tonsillo− pharyngitis.Zulkifli, Fachri H, Efiaty S, Yunisaf M H, Iskandar N. Current medical research and opinion, {Curr−Med−Res−Opin}, 1984, vol. 8, no. 10, p. 708−13, |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26525 |
| Study title: A comparative trial of cephaloridine and erythromycin in hospitalized pneumonic patients.Sterner G, Fransén H, Tunevall G, Svedmyr A. Postgraduate medical journal, {Postgrad−Med−J}, Aug 1967, vol. 43, p. Suppl 43:53−4, |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26563 |
| Study title: A comparative trial of three proprietary antibiotic preparations used in the treatment of acute infections.Myers W H. The British journal of clinical practice, {Br−J−Clin−Pract}, Aug 1969, vol. 23, no. 8, p. 327−9 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26558 |
| Study title: A comparison of albuterol and erythromycin for the treatment of acute bronchitis. Hueston WJ. The Journal of family practice, Nov 1991, vol. 33, no. 5, p. 476−80. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26486 |
| Study title: A comparison of clindamycin and erythromycin in beta--hemolytic streptococcal infections.Levine M K, Berman J D. Journal of the Medical Association of Georgia, {J−Med−Assoc−Ga}, Mar 1972, vol. 61, no. 3, p. 108−11 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26551 |
| Study title: A comparison of erythromycin and cefadroxil in the prevention of flare−ups from asymptomatic teeth with pulpal necrosis and associated periapical pathosis. Morse DR, Furst ML, Lefkowitz RD, D Angelo D, Esposito JV. Oral surgery oral medicine and oral pathology, May 1990, vol. 69, no. 5, p. 619−30. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26494 |
| Study title: A comparison of erythromycin and flucloxacillin in the treatment of infected skin lesions in general practice. Baig A, Grillage MG, Welch RB. The British journal of clinical practice, { Mar 1988, vol. 42, no. 3, p. 110−5. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26503 |
| Study title: A comparison of erythromycin and methacycline in the treatment of common bacterial infections.Wiersum J, Pugliese W, Mesches D, Henriquez C. Current therapeutic research clinical and experimental, {Curr−Ther− Res−Clin−Exp}, Apr 1969, vol. 11, no. 4, p. 156−64, ISSN: 0011−393X. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26559 |
| Study title: A comparison of sodium fusidate ointment ('Fucidin') alone versus oral antibiotic therapy in soft−tissue infections.Pakrooh H. Current medical research and opinion, {Curr−Med−Res−Opin},, vol. 5, no. 4, p. 289−94, |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26545 |
| Study title: A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibioticsin the treatment of skin infections in general practice. Villiger J W, Robertson W D, Kanji K, Ah Chan M, Fetherston J, Hague I K, Haycock D, Hunter P. Current medical research and opinion, {Curr−Med−Res−Opin}, 1986, vol. 10, no. 5, p. 339−45, ISSN:0300−7995. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26513 |
| Study title: A Double-blind study of Stiemycin vs erythromycin fluid (4%) in the treatment of acne. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): Article 45_Ref_ C0164_Final For Submission_27 Oct 2011.xlsx |
| View full study record |
| Document reference: 26574 |
| Study title: Testung der Verträglichkeit einer alkoholischen Lösung mit 2% Erythromycin bei dermatologischen Erkrankungen |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26414 |
| Study title: The value of antibiotics in minor respiratory illness in children. A controlled trial.Gordon M, Lovell S, Dugdale A E. The Medical journal of Australia, {Med−J−Aust}, 2 Mar 1974, vol. 1, no. 9, p. 304−6, ISSN: 0025−729X |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26549 |
| Study title: Tonsillar tissue penetration of dirithromycin after multiple doses. Benson J M, Arnold J, Manning S C, Coleman D L, Sides G D, Conforti P M, Lemon E, Watkins V S. Journal of clinical pharmacology, { Sep 1996, vol. 36, no. 9, p. 832 7. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26455 |
| Study title: Topical mupirocin vs. systemic erythromycin treatment for pyoderma. McLinn S. The Pediatric infectious disease journal, Nov 1988, vol. 7, no. 11, p. 785−90. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26502 |
| Study title: Trachoma therapy with topical tetracycline and oral erythromycin: a comparative trial. Dawson C R, Daghfous T, Hoshiwara I, Ramdhane K, Kamoun M, Yoneda C, Schachter J. Bulletin of the World Health Organization, {Bull−World−Health−Organ}, 1982, vol. 60, no. 3, p. 347−55. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26534 |
| Study title: Treatment of chlamydial urethritis in men and Chlamydia trachomatis− positive female partners: comparison of erythromycin and tetracycline in treatment courses of one week. Scheibel J H, Kristensen J K, Hentzer B, Secher L, Ullman S, Verdich J, Weismann K. Sexually transmitted diseases, {Sex−Transm−Dis}, Jul−Sep 1982, vol. 9, no. 3, p. 128−31. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26533 |
| Study title: Treatment of community−acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin−clavulanic acid and erythromycin. Lode H, Garau J, Grassi C, Hosie J, Huchon G, Legakis N, Segev S, Wijnands G. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology, Dec 1995, vol. 8, no. 12, p. 1999−2007 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26459 |
| Study title: Treatment of diphtheria carriers: benzathine penicillin, erythromycin, and clindamycin. McCloskey R V, Green M J, Eller J, Smilack J. Annals of internal medicine, {Ann−Intern−Med}, Dec 1974, vol. 81, no. 6, p. 788−91, ISSN: 0003−4819. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26548 |
| Study title: Treatment of kerions. Honig PJ, Caputo GL, Leyden JJ, McGinley K, Selbst SM, McGravey AR. Pediatric dermatology, Mar 1994, vol. 11, no. 1, p. 69−71. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26467 |
| Study title: Treatment of Lyme disease. Steere A C, Green J, Hutchinson G J, Rahn D W, Pachner A R, Schoen R T, Sigal L H,Taylor E, Malawista S E. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene. Series A Medical microbiology infectiousdiseases virology parasitology, {Zentralbl−Bakteriol−Mikrobiol−Hyg−A}, Feb 1987, vol. 263, no. 3, p.352−6, ISSN: 0176−6724. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26512 |
| Study title: Treatment of patients with a history of recurrent tonsillitis due to group A beta−hemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin, and clindamycin. Brook I, Hirokawa R. Clinical pediatrics, {Clin−Pediatr−Phila}, Jun 1985, vol. 24, no. 6, p. 331−6, ISSN: 0009−9228. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26520 |
| Study title: Triple therapy with Nexium in children with Hp infection |
| Active substance: ESOMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26615 |
| Study title: Safety and Immunogenicity of Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis (TdcP) Vaccine Compared to Tetanus and Diphtheria Toxoids Adsorbed (Td) in Adolescents and Adults 11-64 Years of Age |
| Active substance: Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47291 |
| Study title: Safety and Immunogenicity of Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis (TdcP) Vaccine Compared to Tetanus and Diphtheria Toxoids Adsorbed (Td) in Adolescents and Adults 11-64 Years of Age |
| Active substance: Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47292 |
| Study title: Safety and Immunogenicity of Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis (TdcP) Vaccine Compared to Tetanus and Diphtheria Toxoids Adsorbed (Td) in Adolescents and Adults 11-64 Years of Age |
| Active substance: Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47293 |
| Study title: Safety of four acellular pertussis combination vaccines (Infantrix-IPV, Boostrix, Covaxis and repevax) given a booster dose to six-year-old Finnish children |
| Active substance: Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47294 |
| Study title: A double-blind, parallel group, clinical determination of the level of P.Acnes erythromycin resistance before, during and after treatment with a gel containing isotretinoin 0.05%/ erythromycin 2% and a gel containing erythromycin (2%) in patients suffering from mild to moderate acne vulgaris |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26411 |
| Study title: A double−blind randomized study of the effect of erythromycin in preventing pelvic inflammatory disease after first trimester abortion. Dire DJ, Hogan DE, Walker JS. Pediatric emergency care, Aug 1992, vol. 8, no. 4, p. 194−9. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26478 |
| Study title: A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis. Gaillat J. The Journal of antimicrobial chemotherapy, Mar 1993, vol. 31 Suppl C, p.139−51 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26473 |
| Study title: Randomised comparative assessment of the immunogenicity and reactogenicity of 3 different lots of SmithKline Beecham Biologicals' Haemophilus influenzae type b (PRP-TT) and the Pasteur/Mérieux Haemophilus type vaccine (PRP-T), administered to healthy infants as a primary vaccination course of three consecutive doses at 3, 4 and 5 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41129 |
| Study title: A phase III clinical trial of antibiotics to reduce chorioamnionitis related perinatal HIV 1 transmission.Taha Taha E, Brown Elizabeth R, Hoffman Irving F, Fawzi Wafaie, Read Jennifer S, Sinkala Moses, Martinson Francis E A, Kafulafula George, Msamanga Gernard, Emel Lynda, Adeniyi Jones Samuel, Goldenberg Robert. AIDS (London England), { 12 Jun 2006, vol. 20, no. 9, p. 1313 21, |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26419 |
| Study title: A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children. Roy S K, Islam A, Ali R, Islam K E, Khan R A, Ara S H, Saifuddin N M, Fuchs G J. Transactions of the Royal Society of Tropical Medicine and Hygiene, Jul Aug 1998, vol. 92, no. 4, p. 460 2. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26446 |
| Study title: A randomized study of antibiotic therapy in idiopathic preterm labor. Morales WJ, Angel JL, O’Brien WF, Knuppel RA, Finazzo M. Obstetrics and gynecology, Dec 1988, vol. 72, no. 6, p. 829−33. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26504 |
| Study title: A randomized, blinded, placebo−controlled trial of antibiotics in idiopathic preterm labor. Newton ER, Dinsmoor MJ, Gibbs RS. Obstetrics and gynecology, Oct 1989, vol. 74, no. 4, p. 562−6. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26498 |
| Study title: A randomized, double blind, placebo controlled trial of single dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya.Malonza I M, Tyndall M W, Ndinya Achola J O, Maclean I, Omar S, Mac Donald K S, Perriens J, Orle K, Plummer F A, Ronald A R, Moses S. The Journal of infectious diseases, Dec 1999, vol. 180, no. 6, p. 1886 93. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26436 |
| Study title: A study of gastric emptying in chronic renal failure.Alimchandani A, Pai dhungat J V. The Journal of the Association of Physicians of India, Nov 1997, vol. 45, no. 11, p. 835 8; Alimchandani A, Pai dhungat J V. The Journal of the Association of Physicians of India, Nov 1997, vol. 45, no. 11, p. 835 8 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26432 |
| Study title: Ad Hoc Committee report: systemic antibiotics for treatment of acne vulgaris: efficacy and safety. No authors listed Archives of dermatology, {Arch−Dermatol}, Dec 1975, vol. 111, no. 12, p. 1630−6, 59 refs, |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26547 |
| Study title: Addition of parenteral cefoxitin to regimen of oral antibiotics for elective colorectal operations. A randomized prospective study. Schoetz DJ Jr, Roberts PL, Murray JJ, Coller JA, Veidenheimer MC. Annals of surgery, Aug 1990, vol. 212, no. 2, p. 209−12. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26491 |
| Study title: Adequate macrolide treatment schedules for uterine cervicitis caused by Chlamydia trachomatis. Mikamo H, Sato Y, Hayasaki Y, Tamaya T. Chemotherapy, { Sep Oct 1999, vol. 45, no. 5, p. 396 8 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26437 |
| Study title: Treatment of the early manifestations of Lyme disease. Steere A C, Hutchinson G J, Rahn D W, Sigal L H, Craft J E, DeSanna E T, Malawista S E. Annals of internal medicine, {Ann−Intern−Med}, Jul 1983, vol. 99, no. 1, p. 22−6, ISSN: 0003−4819. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26529 |
| Study title: (Trials of early syphilis therapy with erythromycin). Próby leczenia kily wczesnej erytromycyna.Wojtkiewiczowa J, Toruniowa B. Przegla̧d dermatologiczny, {Przegl−Dermatol}, Sep−Oct 1965, vol. 52, no. 5, p. 479−84, |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26565 |
| Study title: Twice−a−day regimen of erythromycin base is effective in the treatment of acutestreptococcal tonsillitis. Hovi T, Svahn T, Valtonen V. Scand J Infect Dis. 1987;19(6):661-6. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26508 |
| Study title: Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.Lappin Graham, Kuhnz Wilhelm, Jochemsen Roeline, Kneer Johannes, Chaudhary Ajai, Oosterhuis Berend, Drijfhout Willem Jan, Rowland Malcolm, Garner R Colin. Clinical pharmacology and therapeutics, Sep 2006, vol. 80, no. 3, p. 203 15, |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26418 |
| Study title: Use of rifampin with penicillin and erythromycin in the treatment of psoriasis. Preliminary report. Rosenberg E W, Noah P W, Zanolli M D, Skinner R B Jr, Bond M J, Crutcher N. Journal of the American Academy of Dermatology, {J−Am−Acad−Dermatol}, May 1986, vol. 14, no. 5 Pt 1, p. 761−4, ISSN: 0190−9622. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26517 |
| Study title: Ruptured intracranial mycotic aneurysm: An unusual infectious complication following craniofacial surgery. |
| Active substance: Ethyl esters of iodized fatty acids of poppy seed oil |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39922 |
| Study title: Efficacy of Latigen B in the prevention of bacterial respiratory infections; 2004; 61; 1, 19-27 |
| Active substance: Estratti antigenici |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41218 |
| Study title: Ethambutol dosage for the treatment of children: literature review and recommendations 2006 |
| Active substance: ETHAMBUTOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26631 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY ON THE INCIDENCE OF CERVICAL INFECTIONS DUE TO CHLAMYDIA TRACHOMATIS IN WOMEN CONSULTING A FAMILY PLANNING CENTER |
| Active substance: DOXYCYCLINE |
| Study summary document link (including results): DXC-P-86-002 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 26332 |
| Study title: Administración de eritromicina intraparto para la interrupción de la transmisión vertical del Ureaplasma urealyticum y su posible relación con el desarrollo de displasia broncopulmonar en neonatos de menos de 32 semanas de edad gestacional. Proyecto de estudio multicéntrico. (Administration of intrapartum erythromycin for the interruption of the vertical transmission of Ureaplasma urealyticum and its possible relation to the development of bronchopulmonary dysplasia in neonates with less than 32 weeks gestation. Multicenter study). Salcedo Abizanda S, Cabero Roura L, Andreu Domingo A, Lucaya Layret J, Perapoch López J, Casellas Caro M, Fernández Pérez F, Campins Martí M, Torán Fuentes N, Peguero Monforte G. Anales españoles de pediatría, {An Esp Pediatr}, Jun 1997, vol. Spec No 1, p. 73 7. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26454 |
| Study title: Adverse drug reactions (ADRs) in hospitalized pediatric patients. A prospective study. González Martin G, Caroca C M, Paris E. International journal of clinical pharmacology and therapeutics, Oct 1998, vol. 36, no. 10, p. 530 3. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26444 |
| Study title: All Wales surveillance of methicillin resistant Staphylococcus aureus (MRSA): the first year's results. Morgan M, Salmon R, Keppie N, Evans Williams D, Hosein I, Looker D N. The Journal of hospital infection, Mar 1999, vol. 41, no. 3, p. 173 9. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26439 |
| Study title: Analiza biocenozy kanalu szyjki macicy u ciezarnych. (The analysis of the uterine cervix biocenosis in pregnant women).Kazimierak Wojciech, Swierczewski Arkadiusz, Kowalska Koprek Urszula, Karowicz Bilinska Agata, Berner Trabska Marlena, Nowak Zbigniew, Kus Ewa. Ginekologia polska, { Mar 2007, vol. 78, no. 3, p. 214 7 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26417 |
| Study title: (Analysis of cases allowed to cease erythromycin therapy for diffuse panbronchiolitis comparative study between patients with cessation of the therapy and patients continuing the therapy). Shirai R, Abe K, Yoshinaga M, Ishimatsu Y, Matsubara Y, Kawakami K, Iida K, Fujii T, Kawamoto S, Kaseda M, Kadota J, Kohno S. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, Nov 1997, vol. 71, no. 11, p. 1155 61 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26453 |
| Study title: Anti invasive activity of bovine lactoferrin towards group A streptococci. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26427 |
| Study title: Antibiotic prophylaxis in intraoral wounds. Altieri M, Brasch L, Getson P. The American journal of emergency medicine, {Am−J−Emerg−Med}, Nov 1986, vol. 4, no. 6, p. 507−10 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26515 |
| Study title: Antibiotic treatment of sinusitis in general practice. A double−blind study comparing ofloxacin and erythromycin. Husfeldt P, Egede F, Nielsen PB. European archives of oto−rhino−laryngology : official journal of the European Federation of Oto−Rhino−Laryngological Societies (EUFOS) : affiliated with the German Society for Oto−Rhino−Laryngology − Head and Neck Surgery, 1993, vol. 250 Suppl 1, p. S23−5. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26474 |
| Study title: Antibiotics for whooping cough (pertussis).Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Cochrane database of systematic reviews (Online), 2005 (epub), no.1, p. CD004404 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26415 |
| Study title: Antibiotics in whooping cough. No Authors listed Drug and therapeutics bulletin, {Drug−Ther−Bull}, 17 Nov 1986, vol. 24, no. 23, p. 91−2, ISSN: 0012−6543. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26514 |
| Study title: Antimicrobial therapy in preterm premature rupture of membranes: results of a prospective, double−blind, placebo−controlled trial of erythromycin. McGregor JA, French JI, Seo K. American journal of obstetrics and gynecology, Sep 1991, vol. 165, no. 3, p 632−40. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26487 |
| Study title: Antimicrobial therapy of chancroid: effectiveness of erythromycin. Plummer F A, D Costa L J, Nsanze H, Maclean I W, Karasira P, Piot P, Fast M V, Ronald A R. The Journal of infectious diseases, {J−Infect−Dis}, Oct 1983, vol. 148, no. 4, p. 726−31. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26528 |
| Study title: Antimicrobial treatment of pertussis.Bass J W, Klenk E L, Kotheimer J B, Linnemann C C, Smith M H. The Journal of pediatrics, {J−Pediatr}, Nov 1969, vol. 75, no. 5, p. 768−81, ISSN: 0022−3476. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26557 |
| Study title: Assessment of the potential pharmacokinetic and pharmacodynamic interactions between erythromycin and argatroban. Tran J Q, Di Cicco R A, Sheth S B, Tucci M, Peng L, Jorkasky D K, Hursting M J, Benincosa L J. Journal of clinical pharmacology, {May 1999, vol. 39, no. 5, p. 513 9. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26440 |
| Study title: Landman-Parker J et al Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90.J Clin Oncol 2000 Apr;18(7):1500-7 |
| Active substance: ETOPOSIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26771 |
| Study title: EFFICACY AND TOLERATION OF VIBRAMYCIN VS. CEFACLOR IN THE TREATMENT OF EXACERBATION OF CHRONIC BRONCHOPATHY. |
| Active substance: DOXYCYCLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26335 |
| Study title: FRAGMIN P / - FORTE FOR RISK ADAPTED PERI- AND POSTOPERATIVE PROPHYLAXIS OF THROMBOSIS IN HOSPITALIZED PATIENTS |
| Active substance: DOXYCYCLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26325 |
| Study title: OPEN, NON-COMPARATIVE STUDY ON THE EFFICACY AND SAFETY OF VIBRAMYCIN IN THE TREATMENT OF ACUTE RESPIRATORY INFECTIONS |
| Active substance: DOXYCYCLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26349 |
| Study title: Azithromycin in the treatment of cholera in children.Bhattacharya M K, Dutta D, Ramamurthy T, Sarkar D, Singharoy A, Bhattacharya S K. Acta paediatrica (Oslo Norway : 1992), , Jun 2003, vol. 92, no. 6, p. 676 8 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26425 |
| Study title: Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group. Daniel R The Journal of international medical research, Nov− Dec 1991, vol. 19, no. 6, p.433−45. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26481 |
| Study title: Azitromitsin v lechenii sifilisa. (Azithromycin in the treatment of syphilis). Mashkilleison AL. Antibiotiki i khimioterapiiÍa = Antibiotics and chemoterapy (sic) / Ministerstvo meditsinskoi i mikrobiologicheskoi promyshlennosti SSSR, Jun 1994, vol. 39, no. 6, p. 36−8. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26461 |
| Study title: Bacteremia of dental origin and antimicrobial sensitivity following oral surgical procedures in children. Roberts G J, Watts R, Longhurst P, Gardner P. Pediatric dentistry, {Pediatr Dent}, Jan Feb 1998, vol. 20, no. 1, p. 28 36. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26451 |
| Study title: Bacterial etiology and antimicrobial treatment of exudative otitis media: relation of antibiotic therapy to relapses.Howie V M, Ploussard J H. Southern medical journal, {South−Med−J}, Feb 1971, vol. 64, no. 2, p. 233−9, ISSN: 0038−4348. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26554 |
| Study title: Broad spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group. Kenyon S L, Taylor D J, Tarnow Mordi W. Lancet, {Lancet}, 31 Mar 2001, vol. 357, no. 9261, p. 989 94 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26431 |
| Study title: Cervicovaginal microflora and pregnancy outcome: results of a double− blind, placebo−controlled trial of erythromycin treatment. Britton JW, Fajardo JE, Krafte Jacobs B The Journal of pediatrics, Nov 1990, vol. 117, no. 5, p. 827−9. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26489 |
| Study title: Chlamydia and gonorrhoea in pregnancy: effectiveness of diagnosis and treatment in Botswana.Romoren M, Rahman M, Sundby J, Hjortdahl P. Sexually transmitted infections, { Oct 2004, vol. 80, no. 5, p. 395 400 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26422 |
| Study title: Chronic sinusitis in children with respiratory allergy: the role of antimicrobials. Rachelefsky G S, Katz R M, Siegel S C. The Journal of allergy and clinical immunology, {J−Allergy−Clin− Immunol}, Apr 1982, vol. 69, no. 4, p. 382−7, ISSN: 0091−6749. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26537 |
| Study title: Clindamycin therapy for Chlamydia trachomatis in women. Campbell WF, Dodson MG. American journal of obstetrics and gynecology, {, Feb 1990, vol. 162, no. 2, p.343−7. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26495 |
| Study title: Clinical and bacteriological evaluation of tetracycline and erythromycin in acne vulgaris. Al Mishari M A. Clinical therapeutics, {Clin−Ther}, 1987, vol. 9, no. 3, p. 273−80, ISSN: 0149−2918. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26511 |
| Study title: Clinical comparison of antibiotic combinations in the treatment of peritonitis and related mixed aerobic−anaerobic surgical sepsis.; Stone H H, Fabian T C. World journal of surgery, {World−J−Surg}, Jul 1980, vol. 4, no. 4, p. 415−21, ISSN: 0364−2313. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26538 |
| Study title: Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group.Plouffe J, Schwartz D B, Kolokathis A, Sherman B W, Arnow P M, Gezon J A, Suh B, Anzuetto A, Greenberg R N, Niederman M, Paladino J A, Ramirez J A, Inverso J, Knirsch C A. Antimicrobial agents and chemotherapy, Jul 2000, vol. 44, no. 7, p.1796 802 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26434 |
| Study title: (Clinical evaluation of josamycin for the treatment of Mycoplasma pneumonia in children).Motohiro T, Tanaka K, Koga T, Shimada Y, Tomita N, Sakata Y, Fujimoto T, Nishiyama T, Ishimoto K, Tominaga K, et al. The Japanese journal of antibiotics, {Jpn−J−Antibiot}, Jun 1983, vol. 36, no. 6, p. 1359−76, |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26526 |
| Study title: Clinical trial of a new antibiotic.Newell A C. The Medical journal of Australia, {Med−J−Aust}, 15 Aug 1970, vol. 2, no. 7, p. 321−6, ISSN: 0025−729X. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26555 |
| Study title: Clinical trial of erythromycin stearate suspension.McLeay A C, Beveridge J. The Medical journal of Australia, {Med−J−Aust}, 10 Apr 1971, vol. 1, no. 15, p. 793−6, ISSN: 0025−729X. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26553 |
| Study title: études cliniques ouvertes multicentriques ayant inclus des enfants et nourissons |
| Active substance: ECONAZOLE AND TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26357 |
| Study title: In vivo study of the release of triamcinolone acetonide from 3 diferent vehicles (9-78 yrs) |
| Active substance: ECONAZOLE AND TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26358 |
| Study title: A phase IV double-blind multicenter study comparing the antipyretic effectiveness of aspirin, acetaminophen, choline salicylate and placebo in febrile children. Jun 1991.A phase IV double-blind multicenter study comparing the antipyretic effectiveness of aspirin, acetaminophen, choline salicylate and placebo in febrile children. Jun 1991. |
| Active substance: DIRITHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26233 |
| Study title: Dirithromycin vs erythromycin base in streptococcal pharyngitis/tonsillitis, acute superimposed on chronic bronchitis, lobar pneumonia/bronchopneumonia, and bacterial skin/skin-structure infectionsA phase IV double-blind multicenter study comparing the antipyretic effectiveness of aspirin, acetaminophen, and placebo in febrile children. Aug 1992. |
| Active substance: DIRITHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26232 |
| Study title: (Clinical use of josamycin in comparison with erythromycin in respiratory and urinary tract infections). Impiego clinico della josamicina a confronto con l'eritromicina nelle infezioni del tratto respiratorio eurinario.Lazzaro A, Vettori G, Bagozzi B. La Clinica terapeutica, {Clin−Ter}, 30 Sep 1985, vol. 114, no. 6, p. 469−73, ISSN: 0009−9074. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26519 |
| Study title: Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections. Wasilewski M M, Wilson M G, Sides G D, Stotka J L. The Journal of antimicrobial chemotherapy, Aug 2000, vol. 46, no. 2, p. 255 62 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26433 |
| Study title: Comparative irritancy testing of the acne products: Isotrexin, Isotretinoin 0.05%, Benzoyl peroxide 5.0% + erythromycin 3.0%, Adapalene 0.1%, Erythromycin 4.0% + zinc acetate 1.2%. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26413 |
| Study title: Comparative trial of erythromycin and sulphatrimethoprim in the treatment of tetracycline−resistant Vibrio cholerae O1. Burans JP, Podgore J, Mansour MM, Farah AH, Abbas S, Abu Elyazeed R, Woody JN. Transactions of the Royal Society of Tropical Medicine and Hygiene, Nov−Dec 1989, vol. 83, no. 6, p. 836−8. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26497 |
| Study title: Comparative trial of erythromycin and tetracycline in common infections found in general practice.Gomez J R, Gomez G. The British journal of clinical practice, {Br−J−Clin−Pract}, 11 Nov 1968, vol. 22, no. 11, p. 475−7, |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26561 |
| Study title: Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias. Schönwald S, Gunjaca M, Kolacny Babic L, Car V, Gosev M. The Journal of antimicrobial chemotherapy, Jan 1990, vol. 25 Suppl A, p.123−6. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26496 |
| Study title: Comparison of erythromycin and isoniazid in treatment of adverse reactions to BCG vaccination. Hanley S P, Gumb J, Macfarlane J T. British medical journal (Clinical research ed.), {Br−Med−J−Clin−Res−Ed }, 30 Mar 1985, vol. 290, no. 6473, p. 970, ISSN: 0267−0623. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26521 |
| Study title: Comparison of mupirocin and erythromycin in the treatment of impetigo. Britton JW, Fajardo JE, Krafte Jacobs B The Journal of pediatrics, Nov 1990, vol. 117, no. 5, p. 827−9. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26490 |
| Study title: Comparison of oral erythromycin, local administration of streptomycin and placebo therapy for nonsuppurative Bacillus Calmette Guérin lymphadenitis. Kuyucu N, Kuyucu S, Ocal B, Teziç T. The Pediatric infectious disease journal, Jun 1998, vol. 17, no. 6, p. 524 5. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26448 |
| Study title: Comparison of single and multiple dose pharmacokinetics using clinical bioequivalence data and Monte Carlo simulations. el Tahtawy AA, Jackson AJ, Ludden TM. Pharmaceutical research, Sep 1994, vol. 11, no. 9, p. 1330−6. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26463 |
| Study title: Cost−effectiveness of erythromycin versus mupirocin for the treatment of impetigo in children. Rice TD, Duggan AK, DeAngelis C. Pediatrics, Feb 1992, vol. 89, no. 2, p. 210−4. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26482 |
| Study title: (Course of dysentery and the specific alteration of the neutrophils in children in the use of monomycin and a diet with an increased protein content). Techenie dizenterii i spetsificheskaia al'teratsiia neitrofilov krovi u detei v usloviiakh primeneniia monomitsina i diety s povyshennym soderzhaniem belka.Vereshchagin I A, Chernichenko A M. Antibiotiki. 1979 Jul;24(7):532-5. Russian |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26543 |
| Study title: Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N−demethylation. Jones DR, Gorski JC, Haehner BD, O’Mara EM Jr, Hall SD. Clinical pharmacology and therapeutics, Oct 1996, vol. 60, no. 4, p. 374−84. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26456 |
| Study title: Double−blind comparative trial of trimethoprim/sulfamethopyrazine once daily vs erythromycin 4 X daily in patients with ENT infections. Federspil P, Koch J. International journal of clinical pharmacology therapy and toxicology, Oct 1983, vol. 21, no. 10, p. 535−9, ISSN: 0174−4879. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26527 |
| Study title: Double−blind placebo−controlled trial of erythromycin in the treatment of clinical campylobacter infection. Mandal B K, Ellis M E, Dunbar E M, Whale K. The Journal of antimicrobial chemotherapy, {J−Antimicrob−Chemother}, Jun 1984, vol. 13, no. 6, p.619−23, ISSN: 0305−7453. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26524 |
| Study title: A double-blind, parallel group, clinical determination of the level of P.Acnes erythromycin resistance before, during and after treatment with a gel containing isotretinoin 0.05%/ erythromycin 2% and a gel containing erythromycin (2%) in patients suffering from mild to moderate acne vulgaris |
| Active substance: ERYTHROMYCIN AND ISOTRETINOIN |
| Study summary document link (including results): Article 45_Ref_C0366_Final For Submission_27 Oct 2011.xls |
| View full study record |
| Document reference: 48302 |
| Study title: Comparative irritancy testing of the acne products: Isotrexin, Isotretinoin 0.05%, Benzoyl peroxide 5.0% + erythromycin 3.0%, Adapalene 0.1%, Erythromycin 4.0% + zinc acetate 1.2%. |
| Active substance: ERYTHROMYCIN AND ISOTRETINOIN |
| Study summary document link (including results): Article 45_Ref_C0640_Final For Submission_27 Oct 2011.xlsx |
| View full study record |
| Document reference: 48304 |
| Study title: Isotrexin Forte (0.1% isotretinoin, 4% erythromycin); two pilot tests followed by a 48 hour human patch test for skin irritation (Isotrexin included as a comparator). |
| Active substance: ERYTHROMYCIN AND ISOTRETINOIN |
| Study summary document link (including results): Article 45_Ref_ C0488_Final For Submission_27 Oct 2011.xlsx |
| View full study record |
| Document reference: 48303 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE PO VS. AMPHOTERICIN B SUSPENSION IN PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27598 |
| Study title: Double−blind study: Cleocin Palmitate and Erythrocin Pediatric in otitis media in children.Pugliese W M, Mesches D N, Wiersum J, Henriquez C L 3rd, Krivda J F. Current therapeutic research clinical and experimental, {Curr−Ther− Res−Clin−Exp}, Jan 1972, vol. 14, no. 1, p. 31−4, ISSN: 0011−393X. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26552 |
| Study title: Effect of azidocillin, erythromycin, clindamycin and doxycycline on postoperative complications after surgical removal of impacted mandibular third molars.Bystedt H, Nord C E, Nordenram A. International journal of oral surgery, {Int−J−Oral−Surg}, Jun 1980, vol. 9, no. 3, p. 157−65. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26539 |
| Study title: Effect of CYP3A inhibition on vesnarinone metabolism in humans. Wandel C, Lang C C, Cowart D C, Girard A F, Bramer S, Flockhart D A, Wood A J. Clinical pharmacology and therapeutics, May 1998, vol. 63, no. 5, p. 506 11. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26449 |
| Study title: Effect of erythromycin and amoxycillin on Bordetella pertussis in the nasopharynx. Trollfors B. Infection, {Infection}, 1978, vol. 6, no. 5, p. 228−30, ISSN: 0300−8126. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26544 |
| Study title: (Effect of midecamycin acetate on intestinal bacterial flora of children, and results of clinical study on midecamycin acetate in the treatment of mycoplasma pneumonia).Motohiro T, Tanaka K, Koga T, Shimada Y, Tomita N, Sakata Y, Fujimoto T, Nishiyama T, Nakajima T, Ishimoto K, Tominaga K, Yamashita F, Yukizane S, Suzuki K, Takajo N, Araki H,Kawano Y, Matsuura S, Imai S, Yuasa T, Tanaka Y, Tsugawa S, Nagayama K, Yamamoto M, Komatsu Y, Tanaka C, Matsuyama M, Koga T, Shiotsuki K, Kinoshita S, Haraguchi K, Matsuo H, Imuta F, Ohta M, Kubota K, Ichikawa K, Harada Y, Nakamura M. The Japanese journal of antibiotics, {Jpn−J−Antibiot}, Nov 1982, vol. 35, no. 11, p. 2491−529, |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26531 |
| Study title: Effect of phenoxymethylpenicillin and erythromycin prophylaxis on anaerobic bacteraemia after oral surgery. Josefsson K, Heimdahl A, von Konow L, Nord C E. The Journal of antimicrobial chemotherapy, {J−Antimicrob−Chemother}, Aug 1985, vol. 16, no. 2, p.243−51, ISSN: 0305−7453. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26518 |
| Study title: Efficacy of neonatal ocular prophylaxis for the prevention of chlamydial and gonococcal conjunctivitis. Hammerschlag MR, Cummings C, Roblin PM, Williams TH, Delke I. N Engl J Med. 1989 Mar 23;320(12):769-72. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26571 |
| Study title: Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma. Fraser-Hurt N, Bailey RL, Cousens S, Mabey D, Faal H, Mabey DC. Bull World Health Organ. 2001;79(7):632-40. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26568 |
| Study title: Efficacy of trimethoprim sulfamethoxazole compared with sulfadoxine pyrimethamine plus erythromycin for the treatment of uncomplicated malaria in children with integrated management of childhood illness dual classifications of malaria and pneumonia.Hamel Mary J, Holtz Timothy, Mkandala Christopher, Kaimila Nyokase, Chizani Nyson, Bloland Peter, Kublin James, Kazembe Peter, Steketee Richard. The American journal of tropical medicine and hygiene, Sep 2005, vol. 73, no. 3, p. 609 15, |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26421 |
| Study title: Erythromycin acistrate and enterocoated pellets of erythromycin base in acute respiratory infections of hospitalized conscripts. Gordin A, Salmi HA, Antikainen R. The Journal of antimicrobial chemotherapy, , Jun 1988, vol. 21 Suppl D, p. 93−9 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26506 |
| Study title: Erythromycin and phenoxymethylpenicillin (penicillin V) in the treatment of respiratory tract infections as related to microbiological findings and serum C−reactive protein. Söderström M, Blomberg J, Christensen P, Hovelius B. Scandinavian journal of infectious diseases, 1991, vol. 23, no. 3, p. 347−54. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26488 |
| Study title: Erythromycin as a prokinetic agent in children.Hall JE, Harmer M. Anaesthesia, May 1996, vol. 51, no. 5, p. 503−4. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26458 |
| Study title: Erythromycin enhances early postoperative contractility of the denervated whole stomach as an esophageal substitute. Collard J M, Romagnoli R, Otte J B, Kestens P J. Annals of surgery, Mar 1999, vol. 229, no. 3, p. 337 43. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26442 |
| Study title: Erythromycin for treatment of acute bronchitis. Franko JP. The Journal of family practice, Sep 1996, vol. 43, no. 3, p. 230−1. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26457 |
| Study title: (Erythromycin in dental practice. Clinical investigation). L'eritromicina nella pratica odontostomatologica. Indagine clinica.Cruciani A. Dental Cadmos, {Dent−Cadmos}, Jun 1979, vol. 47, no. 6, p. 53−7, ISSN: 0011−8524. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26542 |
| Study title: Erythromycin in pityriasis rosea: A double blind, placebo controlled clinical trial. Sharma P K, Yadav T P, Gautam R K, Taneja N, Satyanarayana L. Journal of the American Academy of Dermatology, Feb 2000, vol. 42, no. 2 Pt 1, p. 241 4 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26435 |
| Study title: Erythromycin in the treatment of acute gonococcal urethritis in males.Smith D O Jr, Osick P. Current therapeutic research clinical and experimental, {Curr−Ther− Res−Clin−Exp}, Jan 1969, vol. 11, no. 1, p. 1−4, ISSN: 0011−393X. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26560 |
| Study title: Erythromycin ointment for ocular prophylaxis of neonatal chlamydial infection. Hammerschlag MR, Chandler JW, Alexander ER, English M, Chiang WT, Koutsky L, Eschenbach DA, Smith JR. JAMA. 1980 Nov 21;244(20):2291-3. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26572 |
| Study title: Erythromycin therapy twice daily for streptococcal pharyngitis. Controlled comparison with erythromycin or penicillin phenoxymethyl four times daily or penicillin G benzathine.Shapera R M, Hable K A, Matsen J M. JAMA : the journal of the American Medical Association, {JAMA}, 29 Oct 1973, vol. 226, no. 5, p. 531−5. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26550 |
| Study title: Erythromycin treatment is beneficial for longstanding Moraxella catarrhalis associated cough in children. Darelid J, Löfgren S, Malmvall BE. Scandinavian journal of infectious diseases, 1993, vol. 25, no. 3, p. 323−9. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26470 |
| Study title: (Erythromycin versus amoxicillin for the treatment of pneumonia in children (author's transl)). Erythromycin versus Amoxicillin bei kindlichen Pneumonien.Ruhrmann H, Blenk H. Infection, {Infection}, 1982, vol. 10 Suppl 2, p. S86−91, ISSN: 0300−8126. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26536 |
| Study title: Erythromycin versus cefadroxil in the treatment of skin infections. Heskel NS, Siepman NC, Pichotta PJ, Green EM, Stoll RW. International journal of dermatology, Feb 1992, vol. 31, no. 2, p. 131−3. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26480 |
| Study title: Erythromycin versus metronidazole in the treatment of bacterial vaginosis. Wathne B, Holst E, Hovelius B, Mårdh PA. Acta obstetricia et gynecologica Scandinavica, Aug 1993, vol. 72, no. 6, p. 470−4. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26471 |
| Study title: Erytromycine bij prematuur gebroken vliezen gunstig voor de gezondheid van het kind. (Erythromycin for premature rupture of membranes is beneficial for infant).Buitendijk S E. Nederlands tijdschrift voor geneeskunde, {Ned Tijdschr Geneeskd}, 22 Sep 2001, vol. 145, no. 38, p.1828 31 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26429 |
| Study title: Evaluation of cefadroxil, penicillin and erythromycin in the treatment of streptococcal tonsillopharyngitis. Milatovic D. The Pediatric infectious disease journal, Oct 1991, vol. 10, no. 10 Suppl, p.S61−3. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26485 |
| Study title: Evaluation of oral erythromycin and local isoniazid instillation therapy in infants with Bacillus Calmette−Guérin lymphadenitis and abscesses. Noah PK, Pande D, Johnson B, Ashley D. The Pediatric infectious disease journal, Feb 1993, vol. 12, no. 2, p. 136−9. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26475 |
| Study title: (Evaluation of the efficiency of metronidazole as chemotherapy for acute pericoronitis). Evaluación de la eficacia del metronidazol como quimioterapia de la pericoronaritis aguda.Meiss A, Caride E R. Revista de la Asociación Odontológica Argentina, {Rev−Asoc−Odontol− Argent}, Mar−Apr 1982, vol. 70,no. 2, p. 93−6, ISSN: 0004−4881. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26530 |
| Study title: Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children. Delgado L F, Pferferman A, Solé D, Naspitz C K. Annals of allergy asthma & immunology : official publication of the American College of Allergy Asthma & Immunology, Apr 1998, vol. 80, no. 4, p. 333 7. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26452 |
| Study title: Farmakoterapiia ostrogo tonzillofaringita v ambulatornoi praktike: rezul'taty mnogotsentrovogo farmakoépidemiologicheskogo issledovaniia. (Pharmacotherapy of acute tonsillitis pharyngitis in ambulatory practice: results of a multicenter pharmaco epidemiological study).Kozlov S N, Strachunskii L S, Rachina S A, Dmitrenok O V, Iliushchenko L A, Kuzin V B, Ortenberg E A, Paliutin Sh Kh, Sosonnaia N A. Terapevticheskii arkhiv, 2004, vol. 76, no. 5, p. 45 51 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26423 |
| Study title: Five day dirithromycin therapy is as effective as seven day erythromycin therapy for acute exacerbations of chronic bronchitis. Wasilewski M M, Johns D, Sides G D. The Journal of antimicrobial chemotherapy, Apr 1999, vol. 43, no. 4, p. 541 8 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26438 |
| Study title: TO EVIDENCE THE FAST POTENT AND EFFECTIVE ACTION OF VIBRAMYCIN IN PATIENTS WITH UPPER AND LOWER RESPIRATORY INFECTIONS. |
| Active substance: DOXYCYCLINE |
| Study summary document link (including results): DXC-P-86-002 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 26347 |
| Study title: UNDERSTAND INTERACTION BETWEEN QUININE AND DOXYCYCLINE IN ACUTE MALARIA ATTACKS AND TO ANALYSE THE CORRELATION BETWEEN CLINICAL EFFICACY AND PHARMACOLOGICAL INTERACTION OF THE TWO DRUGS. |
| Active substance: DOXYCYCLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26338 |
| Study title: VIBRAMYCIN 50 MG IN THE TREATMENT O FACIAL ACNE |
| Active substance: DOXYCYCLINE |
| Study summary document link (including results): DXC-CH-86-001 EMA Paediatric Web Synopsis.pdf |
| View full study record |
| Document reference: 26331 |
| Study title: VIBRAMYCIN IN OB/GYN INFECTIONS. |
| Active substance: DOXYCYCLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26342 |
| Study title: VIBRAMYCIN IN THE TREATMENT OF SINUSITIS IN ADULT PATIENTS. |
| Active substance: DOXYCYCLINE |
| Study summary document link (including results): DXC-FWA-86-001 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 26337 |
| Study title: Further studies on the treatment of streptococcal skin infection.Derrick C W, Dillon H C Jr. The Journal of pediatrics, {J−Pediatr}, Oct 1970, vol. 77, no. 4, p. 696−700, ISSN: 0022−3476. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26556 |
| Study title: Group B beta−hemolytic streptococcus: randomized controlled treatment study at term. Merenstein G B, Todd W A, Brown G, Yost C C, Luzier T. Obstetrics and gynecology, {Obstet−Gynecol}, Mar 1980, vol. 55, no. 3, p. 315−8, ISSN: 0029−7844. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26541 |
| Study title: Group B streptococcus (GBS) colonisation among expectant Irish mothers. Kieran E, Matheson M, Mann A G, Efstratiou A A, Butler K, Gorman W. Irish medical journal, Jan Feb 1998, vol. 91, no. 1, p. 21 2. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26450 |
| Study title: HPTN 024 study: histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV 1 infected African population.Goldenberg Robert L, Mudenda Victor, Read Jennifer S, Brown Elizabeth R, Sinkala Moses, Kamiza Steve, Martinson Francis, Kaaya Ephata, Hoffman Irving, Fawzi Wafaie, Valentine Megan, Taha Taha E. American journal of obstetrics and gynecology, Oct 2006 (epub: 26 Jul 2006), vol. 195, no. 4, p. 1065 7 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26420 |
| Study title: Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin. Barton LL, Friedman AD, Sharkey AM, Schneller DJ, Swierkosz EM. Pediatric dermatology, Jun 1989, vol. 6, no. 2, p. 134−8. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26500 |
| Study title: infections of the upper respiratory tract in childhood. Comparison with erythromycin). Valutazione clinica di un antibatterico nuovo: lo xibornolo nella terapia delle infezioni batteriche delle prime vie aeree in età pediatrica. Confronto con eritromicina. Capristo A F, Maiello N, Coppola T, Decimo F, Miraglia del Giudice M Jr, Antignani R G. Minerva pediatrica, {Minerva−Pediatr}, 30 Jun 1986, vol. 38, no. 11−12, p. 503−10, ISSN: 0026−4946. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26516 |
| Study title: Infectious flare−ups and serious sequelae following endodontic treatment: aprospective randomized trial on efficacy of antibiotic prophylaxis in cases ofasymptomatic pulpal−periapical lesions. Morse D R, Furst M L, Belott R M, Lefkowitz R D, Spritzer I B, Sideman B H. Oral surgery oral medicine and oral pathology, {Oral−Surg−Oral−Med− Oral−Pathol}, Jul 1987, vol. 64,no. 1, p. 96−109, ISSN: 0030−4220. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26510 |
| Study title: Influence of macrolide antibiotics on promotion of resistance in the oral flora of children. Kastner U, Guggenbichler J P. Infection, Oct 2001, vol. 29, no. 5, p. 251 6 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26428 |
| Study title: Isotrexin Forte (0.1% isotretinoin, 4% erythromycin); two pilot tests followed by a 48 hour human patch test for skin irritation (Isotrexin included as a comparator). |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26412 |
| Study title: Josamycin versus erythromycin in the treatment of streptococcal pharyngitis in children. Marchisio P, Bigalli L, Massironi E, Besana R, Principi N, Bonino S. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, Jun 1987, vol. 6, no. 2 Suppl, p. 413−4. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26499 |
| Study title: Khimioterapevticheskaia éffektivnost' eritromitsina, rifampitsina i tetratsiklinov pri khlamidioze I mikoplasmoze u detei. (Chemotherapeutic effectiveness of erythromycin, rifampicin and tetracyclines in chlamydiosis and mycoplasmosis in children). Vasilos LV, Rumel NB, Shchuka SS. Antibiotiki i khimioterapiiÍa = Antibiotics and chemoterapy (sic) / Ministerstvo meditsinskoi I mikrobiologicheskoi promyshlennosti SSSR, Jun 1995, vol. 40, no. 6, p. 40−2. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26460 |
| Study title: Klinicheskoe znachenie gribkovo mikrobnykh assotsiatsii i antibakterial'naia terapiia pri khronicheskikh vospalitel'nykh zabolevaniiakh organov dykhaniia u detei. (Clinical significance of fungal and microbial associations and antibacterial therapy for treatment of chronic inflammatory respiratory tract diseases in children). Platonova M M, Sereda E V, Katosova L K. Antibiotiki i khimioterapiiÍa = Antibiotics and chemoterapy (sic) / Ministerstvo meditsinskoi I mikrobiologicheskoi promyshlennosti SSSR, 1998, vol. 43, no. 9, p. 19 23. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26447 |
| Study title: L'associazione amoxicillina−acido clavulanico nelle infezioni batteriche delle vie respiratorie superiori in età pediatrica. Studio clinico controllato. (Amoxicillin−clavulanic acid combination in bacterial infections of the upper respiratory tract in childhood. Controlled clinical study). Boccazzi A, Borzani M, Scotti L. La Pediatria medica e chirurgica : Medical and surgical pediatrics, Jul−Aug 1988, vol. 10, no. 4, p. 395−400. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26501 |
| Study title: Kaneko M et al, Intensified chemotherapy increases the survival rates in patients with stage 4, neuroblastoma with MYCN amplification, J Pediatr Hematol Oncol. 2002 Nov;24(8):613-21 |
| Active substance: ETOPOSIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26937 |
| Study title: Mann JR et al, The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity, J Clin Oncol. 2000 Nov 15;18(22):3809-18 |
| Active substance: ETOPOSIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26850 |
| Study title: Mann JR et al, UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study Group, Med Pediatr Oncol. 1998 Apr;30(4):217-27. Review |
| Active substance: ETOPOSIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26863 |
| Study title: Tebbi CK et al Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study Pediatr Blood Cancer 2006 Feb;46(2):198-202 |
| Active substance: ETOPOSIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26766 |
| Study title: Mass treatment with single-dose azithromycin for trachoma. Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, Natividad-Sancho A, Molina S, Safari S, Shao JF, Courtright P, Peeling RW, West SK, Bailey RL, Foster A, Mabey DC. N Engl J Med. 2004 Nov 4;351(19):1962-71. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26567 |
| Study title: Ob ispol'zovanii oral'nykh antibakterial'nykh sredstv v lechenii ostrykh pnevmonii u detei. (Use of oral antibacterial drugs in the treatment of acute pneumonia in children). Fedorov AM, Tatochenko VK, Khairulin BE. Pediatriia, 1992, no. 4−6, p. 38−42 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26476 |
| Study title: (On the length of resorption of pneumonia infiltration under antibiotic therapy). Zur Resorptionsdauer pneumonischer Infiltrate unter antibiotischer Behandlung.Schuster W. Deutsche medizinische Wochenschrift (1946), {Dtsch−Med−Wochenschr}, 24 Nov 1967, vol. 92, no. 47, p. 2166−8, ISSN: 0012−0472. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26562 |
| Study title: ORACLE antibiotics for preterm prelabour rupture of the membranes: short term and long term outcomes. Kenyon S, Taylor D J, Tarnow Mordi W O. Acta paediatrica (Oslo Norway : 1992). Supplement, 2002, vol. 91, no. 437, p.12 5 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26426 |
| Study title: Oral antibiotic prophylaxis in patients with cancer: a double−blind randomized placebo−controlled trial. Scheibel J H, Kristensen J K, Hentzer B, Secher L, Ullman S, Verdich J, Weismann K. Sexually transmitted diseases, {Sex−Transm−Dis}, Jul−Sep 1982, vol. 9, no. 3, p. 128−31. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26532 |
| Study title: Otitis media with effusion: can erythromycin reduce the need for ventilating tubes? Møller P, Dingsør G. The Journal of laryngology and otology, , Mar 1990, vol. 104, no. 3, p. 200−2. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26493 |
| Study title: Penicillin vs. erythromycin in the treatment of diphtheria. Kneen R, Pham N G, Solomon T, Tran T M, Nguyen T T, Tran B L, Wain J, Day N P, Tran T H, Parry C M, White N J. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Oct 1998, vol. 27, no. 4, p. 845 50. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26443 |
| Study title: Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis. Protzko E, Bowman L, Abelson M, Shapiro A; AzaSite Clinical Study Group. Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3425-9. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26566 |
| Study title: Pivampicillin compared with erythromycin for treating women with genital Chlamydia trachomatis infection. Cramers M, Kaspersen P, From E, Møller BR. Genitourinary medicine, , Aug 1988, vol. 64, no. 4, p. 247−8. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26505 |
| Study title: Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first pass metabolism, CYP2D6 genotype and formulation dependent bioavailability.Kerbusch Thomas, Wählby Ulrika, Milligan Peter A, Karlsson Mats O. British journal of clinical pharmacology, Dec 2003, vol. 56, no. 6, p. 639 52, |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26424 |
| Study title: Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications. Kovarik J M, Hsu C H, McMahon L, Berthier S, Rordorf C. Clinical pharmacology and therapeutics, Sep 2001, vol. 70, no. 3, p. 247 54, |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26430 |
| Study title: Povidone-iodine for ophthalmia neonatorum prophylaxis. Isenberg SJ, Apt L, Yoshimori R, Leake RD, Rich R. Am J Ophthalmol. 1994 Dec 15;118(6):701-6. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26569 |
| Study title: Prevention and treatment of serous otitis media with an oral antihistamine. A double−blind study in pediatric practice.Klein S W, Olson A L, Perrin J, Cunningham D, Hengerer A, Hoekelman R A, Roghmann K J. Clinical pediatrics, {Clin−Pediatr−Phila}, May 1980, vol. 19, no. 5, p. 342−7, ISSN: 0009−9228. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26540 |
| Study title: Primenenie peroral'nykh makrolidnykh i azalidnykh antibiotikov pri bronkholegochnoi patologii u detei. (Use of oral macrolide and azalide antibiotics in children with bronchopulmonary diseases). Sereda EV, Tatochenko VK, Katosova LK. Antibiotiki i khimioterapiiÍa = Antibiotics and chemoterapy (sic) / Ministerstvo meditsinskoi I mikrobiologicheskoi promyshlennosti SSSR, Jul 1994, vol. 39, no. 7, p. 47−53. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26462 |
| Study title: Placebo controlled randomized study of haemophilus influenzae type b capsular polysaccharide tetanus conjugate vaccine (PRP-T) associated or combined with diphtheria- tetanus- pertussis vaccine (DTP) in two month old infants |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40998 |
| Study title: Seven year serological follow-up and surveillance of pertussis |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40997 |
| Study title: AN OPEN, COMPARATIVE STUDY OF EFFICACY AND SAFETY OF FLUCONAZOLE VS. NYSTATIN IN THE TREATMENT OF PEDIATRIC PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28043 |
| Study title: AN OPEN, COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF FLUCONAZOLE 150MG/WEEK VERSUS TERBINAFINE HCL 250MG/DAY IN THE TREATMENT OF PATIENTS WITH CUTANEOUS CANDIDIASIS AND DERMATOPHYTOSIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27664 |
| Study title: AN OPEN, COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF FLUCONAZOLE 150MG/WEEK VERSUS TERBINAFINE HCL 250MG/DAY IN THE TREATMENT OF PATIENTS WITH CUTANEOUS CANDIDIASIS AND DERMATOPHYTOSIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28026 |
| Study title: AN OPEN, COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF TWO FCA DOSAGE REGIMENS AND ITRACONAZOLE IN THE TREATMENT OF PATIENTS WITH PITYRIASIS VERSICOLOR PILOT TRIAL. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27603 |
| Study title: AN OPEN, COMPARATIVE, MULTICENTER AND RANDOMIZED STUDY OF SAFETY AND EFFICACY OF PO FCA (CAP) VS NYSTATIN (SUS) IN THE PREVENTION OF FUNGAL INFECTIONS IN LIVER TRANSPLANT RECIPIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27601 |
| Study title: AN OPEN, COMPARATIVE, MULTICENTER AND RANDOMIZED STUDY OF SAFETY AND EFFICACY OF PO FCA (CAP) VS NYSTATIN (SUS) IN THE PREVENTION OF FUNGAL INFECTIONS IN LIVER TRANSPLANT RECIPIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27964 |
| Study title: AN OPEN, MULTICENTER COMPARATIVE STUDY OF THE EFFICACY SAFETY AND TOLERATION OF ONCE WEEKLY, ORAL FCA 150 MG OR TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS, CRURIS AND PEDIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27460 |
| Study title: AN OPEN, MULTICENTER COMPARATIVE STUDY OF THE EFFICACY SAFETY AND TOLERATION OF ONCE WEEKLY, ORAL FCA 150 MG OR TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS, CRURIS AND PEDIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27824 |
| Study title: AN OPEN, MULTICENTER NON-COMPARATIVE STUDY OF THE EFFICACY, SAFETY AND TOLERATION OF FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27608 |
| Study title: MULTI-CENTER EVALUATION OF FLUCONAZOLE (UK-49,858) AS TREATMENT FOR ACUTE CRYPTOCOCCAL MENINGITIS IN PATIENTS WHO HAVE FAILED TO RESPOND OR HAVE EXPERIENCED UNACCEPTABLE TOXICITY DURING TREATMENT WITH AMPHOTERICIN B |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27348 |
| Study title: MULTI-CENTER EVALUATION OF FLUCONAZOLE (UK-49,858) AS TREATMENT FOR ACUTE CRYPTOCOCCAL MENINGITIS IN PATIENTS WHO HAVE FAILED TO RESPOND OR HAVE EXPERIENCED UNACCEPTABLE TOXICITY DURING TREATMENT WITH AMPHOTERICIN B |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27714 |
| Study title: MULTICENTER STUDY COMPARING TRIFLUCANO AND AMPHOTERICIN BO (ORAL SUSPENSION) IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN HIV & PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27456 |
| Study title: MULTICENTER STUDY COMPARING TRIFLUCANO AND AMPHOTERICIN BO (ORAL SUSPENSION) IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN HIV & PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27820 |
| Study title: MULTICENTER STUDY OF FCA GRANULES AND INJECTABLE SOLUTION IN PEDIATRIC PATIENTS WITH FUNGAL INFECTION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27366 |
| Study title: MULTICENTER STUDY OF FCA GRANULES AND INJECTABLE SOLUTION IN PEDIATRIC PATIENTS WITH FUNGAL INFECTION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27731 |
| Study title: MULTICENTER STUDY OF FLUCONAZOLE IN THE MANAGEMENT OF CANDIDAL AND CRYPTOCOCCAL INFECTION IN ORGAN TRANSPLANT RECIPIENTS. (ORIGINATED AT CENTRAL RESEARCH, GROTON UNDER STUDY NO.056-501 |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27692 |
| Study title: MULTICENTER STUDY OF FLUCONAZOLE IN THE MANAGEMENT OF CANDIDAL AND CRYPTOCOCCAL INFECTION IN ORGAN TRANSPLANT RECIPIENTS. (ORIGINATED AT CENTRAL RESEARCH, GROTON UNDER STUDY NO.056-501 |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28054 |
| Study title: CLINICAL USEFULNESS FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27870 |
| Study title: CLINICAL USEFULNESS OF CONCOMITANT USE OF DIFLUCAN AND G-CSF FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27529 |
| Study title: CLINICAL USEFULNESS OF CONCOMITANT USE OF DIFLUCAN AND G-CSF FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27893 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR PULMONARY ASPERGILLOSIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27545 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR PULMONARY ASPERGILLOSIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27565 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR PULMONARY ASPERGILLOSIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27909 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR PULMONARY ASPERGILLOSIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27929 |
| Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF FUNGAL INFECTIONS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28023 |
| Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF FUNGAL INFECTIONS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28025 |
| Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF OROPHARYNGEAL, GASTRO INTESTINAL, AND URINARY TRACT CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27649 |
| Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF OROPHARYNGEAL, GASTRO INTESTINAL, AND URINARY TRACT CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28011 |
| Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN TREATMENT OF DISSEMINATED CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27458 |
| Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN TREATMENT OF DISSEMINATED CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27822 |
| Study title: EFFICACY AND SAFETY OF FLUCONAZOLE VS. NYSTATIN IN PREVENTION OF FUNGAL INFECTIONS IN LEUKEMIC PATIENTS UNDER GOING REMISSION INDUCTION CHEMO THERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27652 |
| Study title: EFFICACY AND SAFETY OF FLUCONAZOLE VS. NYSTATIN IN PREVENTION OF FUNGAL INFECTIONS IN LEUKEMIC PATIENTS UNDER GOING REMISSION INDUCTION CHEMO THERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28014 |
| Study title: EFFICACY AND SAFETY OF ONCE WEEKLY ORAL FLUCONAZOLE 150MG VS. TOPICAL BIFONAZOLE IN THE TREATMENT OF PATIENTS WITH TINEA PEDIS A MULTICENTER, OPEN, COMPARATIVE STUDY. TX AROUND 6 WEEKS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27660 |
| Study title: EFFICACY AND SAFETY OF ONCE WEEKLY ORAL FLUCONAZOLE 150MG VS. TOPICAL BIFONAZOLE IN THE TREATMENT OF PATIENTS WITH TINEA PEDIS A MULTICENTER, OPEN, COMPARATIVE STUDY. TX AROUND 6 WEEKS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28022 |
| Study title: EFFICACY AND SAFETY OF ORAL FCA IN THE TREATMENT OF DERMATOMYCOSIS, OPEN NON COMPARATIVE STUDY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27655 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL ANEMIA IN GRANULOCYTOPENIC PEDIATRIC PATIENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27507 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL ANEMIA IN GRANULOCYTOPENIC PEDIATRIC PATIENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27871 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27505 |
| Study title: An uncontrolled study of the safety and efficacy of ceftazidime/arginine in children with serious or moderately serious bacterial infections. |
| Active substance: CEFTAZIDIME |
| Study summary document link (including results): Study CART03 Ceftazidime.xls |
| View full study record |
| Document reference: 47113 |
| Study title: Multicentre, non-blind, randomised, parallel-group trial |
| Active substance: ceftazidime |
| Study summary document link (including results): Study CAZM05 Ceftazidime.xls |
| View full study record |
| Document reference: 47115 |
| Study title: Prospective, non-blind,comparative, multicentre study. |
| Active substance: CEFTAZIDIME |
| Study summary document link (including results): Study CAR-T08 Ceftazidime.xls |
| View full study record |
| Document reference: 47114 |
| Study title: AN OPEN, MULTICENTER NON-COMPARATIVE STUDY OF THE EFFICACY, SAFETY AND TOLERATION OF FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27970 |
| Study title: AN OPEN, MULTICENTER NONCOMPARATIVE STUDY OF THE EFFICACY, SAFETY AND TOLERATION OF FCA IN THE TREATMENT OF FUNGURIA/FUNGAL URINARY TRACT INFECTIONS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27605 |
| Study title: AN OPEN, MULTICENTER NONCOMPARATIVE STUDY OF THE EFFICACY, SAFETY AND TOLERATION OF FCA IN THE TREATMENT OF FUNGURIA/FUNGAL URINARY TRACT INFECTIONS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27967 |
| Study title: AN OPEN, MULTICENTER STUDY OF SAFETY AND TOLERATION OF FLUCONAZOLE FAST DISSOLVING TABLETS (FDT) IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27617 |
| Study title: AN OPEN, MULTICENTER STUDY OF SAFETY AND TOLERATION OF FLUCONAZOLE FAST DISSOLVING TABLETS (FDT) IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27979 |
| Study title: DOUBLE BLIND PLACEBO CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE PROPHYLACTIC TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN CA PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27406 |
| Study title: DOUBLE BLIND PLACEBO CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE PROPHYLACTIC TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN CA PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27771 |
| Study title: DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF FLUCONAZOLE TREATMENT FOR CUTANEOUS LEISHMANIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27620 |
| Study title: DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF FLUCONAZOLE TREATMENT FOR CUTANEOUS LEISHMANIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27982 |
| Study title: DOUBLE BLIND, COMPARATIVE STUDY ON THE EFFICACY AND SAFETY OF FCA 100MG/DAY VS. FCA 50MG/DAY IN THE TREATMENT OF TINEA PEDIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27470 |
| Study title: DOUBLE BLIND, COMPARATIVE STUDY ON THE EFFICACY AND SAFETY OF FCA 100MG/DAY VS. FCA 50MG/DAY IN THE TREATMENT OF TINEA PEDIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27834 |
| Study title: DOUBLE-BLIND CLINICAL PHASE 3 STUDY OF FLUCONAZOLE (UK-49,858) IN CUTANEOUS MYCOSISTINEA PEDIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27571 |
| Study title: DOUBLE-BLIND CLINICAL PHASE 3 STUDY OF FLUCONAZOLE (UK-49,858) IN CUTANEOUS MYCOSISTINEA PEDIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27935 |
| Study title: DOUBLE-BLIND PLACEBO CONTROLLED STUDY OF FLUCONAZOLE IN THE PREVENTION OF FUNGAL INFECTIONS IN NEUTROPENIC PATIENTS UNDERGOING THERAPY FOR ACUTE LEUKEMIA |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27345 |
| Study title: DOUBLE-BLIND PLACEBO CONTROLLED STUDY OF FLUCONAZOLE IN THE PREVENTION OF FUNGAL INFECTIONS IN NEUTROPENIC PATIENTS UNDERGOING THERAPY FOR ACUTE LEUKEMIA |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27711 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMATIC MYCOSES ASSOCIATED WITH DIGESTIVE ORGAN MALIGNANCY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27538 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMATIC MYCOSES ASSOCIATED WITH DIGESTIVE ORGAN MALIGNANCY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27540 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMATIC MYCOSES ASSOCIATED WITH DIGESTIVE ORGAN MALIGNANCY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27902 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMATIC MYCOSES ASSOCIATED WITH DIGESTIVE ORGAN MALIGNANCY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27904 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMATIC MYCOSES ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27539 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMATIC MYCOSES ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27552 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMATIC MYCOSES ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27903 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMATIC MYCOSES ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27916 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMATIC MYCOSES IN HOSPITALIZED PATIENTS WITH IVH. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27547 |
| Study title: PHASE 3 CLINICAL STUDY OF FLUCONAZOLE FOR MAINTENANCE THERAPY FOR SUPRESSION OF ITS RELASPE IN CRYPTOCOCCAL MENINGITIS WITH AIDS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27931 |
| Study title: PHASE I COMPARATIVE STUDY OF THE SAFETY, TOLERATION AND PHARMACOKINETICS OF FLUCONAZOLE WHEN ADMINISTERED TO GERIATRIC AND YOUNGER VOLUNTEERS AS SINGLE INTRAVENOUS AND ORAL DOSES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27338 |
| Study title: PHASE I COMPARATIVE STUDY OF THE SAFETY, TOLERATION AND PHARMACOKINETICS OF FLUCONAZOLE WHEN ADMINISTERED TO GERIATRIC AND YOUNGER VOLUNTEERS AS SINGLE INTRAVENOUS AND ORAL DOSES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27704 |
| Study title: PHASE I/PHARMACOKINETIC STUDY OF FLUCONAZOLE (UK-49,858) IN PEDIATRIC CANCER PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27337 |
| Study title: PILOT STUDY OF ORAL FLUCONAZOLE IN THE TREATMENT OF ACUTE CRYPTOCOCCAL MENINGITIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27349 |
| Study title: PILOT STUDY OF ORAL FLUCONAZOLE IN THE TREATMENT OF ACUTE CRYPTOCOCCAL MENINGITIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27715 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27508 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27516 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27522 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27527 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27869 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27872 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27880 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27886 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27891 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27512 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27876 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH LUNG CANCER |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27510 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH LUNG CANCER |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27874 |
| Study title: DOUBLE-BLIND, DOUBLE-DUMMY, COMPARATIVE STUDY ON THE EFFICACY AND SAFETY OF FLUCONAZOLE 100MG/DAY IN THE TREATMENT OF DERMATOMYCOSES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27476 |
| Study title: DOUBLE-BLIND, DOUBLE-DUMMY, COMPARATIVE STUDY ON THE EFFICACY AND SAFETY OF FLUCONAZOLE 100MG/DAY IN THE TREATMENT OF DERMATOMYCOSES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27840 |
| Study title: DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF FLUCONAZOLE IN THE PREVENTION OF FUNGAL INFECTIONS IN NEUTROPENIC PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION. (ORIGINATED AT CENTRAL RESEARCH, GROTON UNDER STUDY NO.057-567 |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27693 |
| Study title: DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF FLUCONAZOLE IN THE PREVENTION OF FUNGAL INFECTIONS IN NEUTROPENIC PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION. (ORIGINATED AT CENTRAL RESEARCH, GROTON UNDER STUDY NO.057-567 |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28055 |
| Study title: DRUG MONITORING PROGRAM |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27685 |
| Study title: PILOT STUDY TO DETERMINE THE FEASIBILITY OF FLUCONAZOLE FOR INDUCTION TREATMENT AND SUPPRESSION OF RELAPSE OF HISTOPLASMOSIS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27701 |
| Study title: PLACEBO CONTROLLED DOUBLE BLIND STUDY OF EFFICACY AND TOLERATION OF FCA IN PROPHYLACTIC TREATMENT OF CHRONIC RECURRENT VAGINAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27428 |
| Study title: PLACEBO CONTROLLED DOUBLE BLIND STUDY OF EFFICACY AND TOLERATION OF FCA IN PROPHYLACTIC TREATMENT OF CHRONIC RECURRENT VAGINAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27793 |
| Study title: POST-MARKETING SURVEILLANCE OF DIFLUCAN (FLUCONAZOLE) |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27634 |
| Study title: POST-MARKETING SURVEILLANCE OF DIFLUCAN (FLUCONAZOLE) |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27996 |
| Study title: PREVENTION OF FUNGAL COLONIZATION AND INFECTION IN INTENSIVE CARE UNIT. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27400 |
| Study title: PREVENTION OF FUNGAL COLONIZATION AND INFECTION IN INTENSIVE CARE UNIT. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27765 |
| Study title: PROPHYLACTIC TREATMENT OF INFECTION IN PEDIATRIC PATIENTS WITH MALIGNANT TUMOR UNDERLYING GRANULOCYTOPENIA. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27497 |
| Study title: PROPHYLACTIC TREATMENT OF INFECTION IN PEDIATRIC PATIENTS WITH MALIGNANT TUMOR UNDERLYING GRANULOCYTOPENIA. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27861 |
| Study title: PROPHYLAXIS OF FUNGAL INFECTION WITH DIFLUCAN IN PATIENTS WITH COLLAGEN DISEASE ON THE LONG TERM, AND LARGE-DOSAGE STEROID THERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27501 |
| Study title: [A nonsteroidal inflammation inhibitor in chronic conjunctivitis] Stodtmeister R, Marquardt R. Fortschr Ophthalmol. 1986;83(2):199-202. [A nonsteroidal inflammation inhibitor in chronic conjunctivitis] Stodtmeister R, Marquardt R. Fortschr Ophthalmol. 1986;83(2):199-202. |
| Active substance: DICLOPHENAC AND TOBRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26092 |
| Study title: Comparison of the efficacy of diclofenac and betamethasone following strabismus surgery. Wright M, Butt Z, McIlwaine G, Fleck B. Br J Ophthalmol. 1997 Apr;81(4):299-301. Comparison of the efficacy of diclofenac and betamethasone following strabismus surgery. Wright M, Butt Z, McIlwaine G, Fleck B. Br J Ophthalmol. 1997 Apr;81(4):299-301. |
| Active substance: DICLOPHENAC AND TOBRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26090 |
| Study title: Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis. D'Angelo G, Lambiase A, Cortes M, Sgrulletta R, Pasqualetti R, Lamagna A, Bonini S. Graefes Arch Clin Exp Ophthalmol. 2003 Mar;241(3):192-5;Epub 2003 Feb 15. Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis. D'Angelo G, Lambiase A, Cortes M, Sgrulletta R, Pasqualetti R, Lamagna A, Bonini S. Graefes Arch Clin Exp Ophthalmol. 2003 Mar;241(3):192-5;Epub 2003 Feb 15. |
| Active substance: DICLOPHENAC AND TOBRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26088 |
| Study title: Placebo controlled randomized study of haemophilus influenzae type b capsular polysaccharide tetanus conjugate vaccine (PRP-T) associated or combined with diphtheria- tetanus- pertussis vaccine (DTP) in two month old infants |
| Active substance: Diphtheria, Tetanus, Acellular Pertussis and Inactivated Poliomyelitis Vaccine, Adsorbed and Haemophilus influenzae type b conjugate vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47153 |
| Study title: Comparative Safety and lmmunogenicity Study of Diphtheria, Tetanus, Acellular Pertussis, Poliomyelitis Vaccine (DTacP-IPV) and Diphtheria, Tetanus, Whole-cell Pertussis, Poliomyelitis Vaccine (TETRACOQ) Given As a Second Booster to 4- to 7-Year-Old Children |
| Active substance: Diphtheria, Tetanus, Acellular Pertussis and inactivated Poliomyelitis Vaccine, adsorbed. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41420 |
| Study title: Comparative Safety and lmmunogenicity Study of Diphtheria,Tetanus, Acellular Pertussis, Poliomyelitis vaccine (DTacP-IPV) and Diphtheria, Tetanus, Poliomyelitis Vaccine (D.T. Polio) Administered as a Booster in Children Aged 8 to 12 years |
| Active substance: Diphtheria, Tetanus, Acellular Pertussis and inactivated Poliomyelitis Vaccine, adsorbed. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41421 |
| Study title: Comparative study of acellular and whole cell pertussis vaccines combined with diphtheria, tetanus and inactivated poliomyelitis type 1, 2, 3 vaccines in healthy infants (primary-immunisation and booster) |
| Active substance: Diphtheria, Tetanus, Acellular Pertussis and inactivated Poliomyelitis Vaccine, adsorbed. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41413 |
| Study title: Comparative study of the safety and immunogenicity of a Diphtheria Tetanus Acellular Pertussis and a Diphtheria Tetanus Whole Cell Pertussis vaccine in Senegalese infants |
| Active substance: Diphtheria, Tetanus, Acellular Pertussis and inactivated Poliomyelitis Vaccine, adsorbed. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41411 |
| Study title: Comparative, randomised, double-blind safety and immunogenicity study of the Mérieux two-component acellular pertussis vaccine and the Mérieux one-component vaccine in healthy adult volunteers |
| Active substance: Diphtheria, Tetanus, Acellular Pertussis and inactivated Poliomyelitis Vaccine, adsorbed. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41406 |
| Study title: DRUG MONITORING PROGRAM |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27686 |
| Study title: DRUG MONITORING PROGRAM |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28047 |
| Study title: DRUG MONITORING PROGRAM |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28048 |
| Study title: DRUG MONITORING PROGRAM (FCA/D/92-508 AB) |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27430 |
| Study title: DRUG MONITORING PROGRAM (FCA/D/92-508 AB) |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27795 |
| Study title: DRUG MONITORING PROGRAM DIFLUCAN |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27433 |
| Study title: DRUG MONITORING PROGRAM DIFLUCAN |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27435 |
| Study title: DRUG MONITORING PROGRAM DIFLUCAN |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27798 |
| Study title: Dose response study of a Diphtheria, Tetanus, acellular Pertussis (DTacP) vaccine in 3-month-old children |
| Active substance: Diphtheria, Tetanus, Acellular Pertussis and inactivated Poliomyelitis Vaccine, adsorbed. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41407 |
| Study title: Evaluation of the PMSV. Diphtheria, Tetanus, Acellular Pertussis Vaccine (DTacP) in Infants, during a NlAlD Multicenter Acellular Pertussis Trial. Comparative Study Between PMSV. DTacP and Two Conventional Whole Cell DTP Vaccines |
| Active substance: Diphtheria, Tetanus, Acellular Pertussis and inactivated Poliomyelitis Vaccine, adsorbed. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41409 |
| Study title: Immunogenicity and reactogenicity of two dosages of acellular pertussis vaccine compared with whole-cell pertussis vaccine at primary (2, 4 and 6 months of age) and booster (15-24 months and 4-6 years of age) immunisation |
| Active substance: Diphtheria, Tetanus, Acellular Pertussis and inactivated Poliomyelitis Vaccine, adsorbed. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41408 |
| Study title: Large Scale Safety Study of the DTacP-IPV (Acellular Tetracoq) Vaccine, Administered in Combination (one injection site) or in Association (two injection sites) with Haemophilus influenzae type b Vaccine (Act-HIB) for Primary and Booster immunisation. |
| Active substance: Diphtheria, Tetanus, Acellular Pertussis and inactivated Poliomyelitis Vaccine, adsorbed. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41415 |
| Study title: Open, Randomised, Comparative Trial of the lmmunogenicity and Safety of two Immunisation Schedules (2-34 months and 24-6 months of age) using Diphtheria, Tetanus, Acellular Pertussis, Polio (DTacP-IPV) Vaccine mixed with Haemophilus influenzae type b (Act-HI B) Vaccine. |
| Active substance: Diphtheria, Tetanus, Acellular Pertussis and inactivated Poliomyelitis Vaccine, adsorbed. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41417 |
| Study title: AN OPEN, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF ONCE WEEKLY ORAL FLUCONAZOLE 150MG IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS OR CRURIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27682 |
| Study title: AN OPEN, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF ONCE WEEKLY ORAL FLUCONAZOLE 150MG IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS OR CRURIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28044 |
| Study title: AN OPEN, MULTICENTER, COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE 150MG ONCE WEEKLY OR ORAL TERBINAFINE 250 MG ONCE DAILY IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS, CRURIS, PEDIS, OR CUTANEOUS CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27378 |
| Study title: AN OPEN, MULTICENTER, COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE 150MG ONCE WEEKLY OR ORAL TERBINAFINE 250 MG ONCE DAILY IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS, CRURIS, PEDIS, OR CUTANEOUS CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27743 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY FOR THE EVALUATION OF FLUCONAZOLE IN EMPIRE FUNGAL TREATMENT IN FEBRILE GRANULOCYTOPENIC CANCER PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27445 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY FOR THE EVALUATION OF FLUCONAZOLE IN EMPIRE FUNGAL TREATMENT IN FEBRILE GRANULOCYTOPENIC CANCER PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27809 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF EFFICACY AND SAFETY OF SINGLE DOSE ORAL FLUCONAZOLE 150MG CAPSULE IN THE TREATMENT OF VAGINAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27632 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF EFFICACY AND SAFETY OF SINGLE DOSE ORAL FLUCONAZOLE 150MG CAPSULE IN THE TREATMENT OF VAGINAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27994 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE 150MG IN THE TREATMENT OF TINEA CORPORIS, CRURIS OR PEDIS OR CUTANEOUS CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27631 |
| Study title: DRUG MONITORING PROGRAM DIFLUCAN |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27800 |
| Study title: DRUG MONITORING PROGRAM DIFLUCAN . |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27437 |
| Study title: DRUG MONITORING PROGRAM DIFLUCAN . |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27802 |
| Study title: DRUG MONITORING PROGRAM DIFLUCAN (FCA-A-94-002AB) 40 PHYSICIANS WITH 5 PATIENTS = 200 PATIENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27369 |
| Study title: DRUG MONITORING PROGRAM DIFLUCAN (FCA-A-94-002AB) 40 PHYSICIANS WITH 5 PATIENTS = 200 PATIENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27734 |
| Study title: DRUG MONITORING PROGRAM DIFLUCAN (FCA-D-95-802AB) 1500 PHYSICIAN WITH 5 PATIENTS = 7500 PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27436 |
| Study title: DRUG MONITORING PROGRAM DIFLUCAN (FCA-D-95-802AB) 1500 PHYSICIAN WITH 5 PATIENTS = 7500 PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27801 |
| Study title: DRUG MONITORING PROGRAM DIFLUCAN (FCA/D/92-509 AB). 500 PHYSICIANS WITH 5 PATIENTS = 2,500 PATIENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27431 |
| Study title: DRUG MONITORING PROGRAM DIFLUCAN (FCA/D/92-509 AB). 500 PHYSICIANS WITH 5 PATIENTS = 2,500 PATIENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27796 |
| Study title: DRUG MONITORING PROGRAM DIFLUCAN DERMAL (FCA-D-94-704AB) 1000 PHYSICIANS WITH 5 PATIENTS = 5000 PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27434 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMATIC MYCOSES IN HOSPITALIZED PATIENTS WITH IVH. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27911 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMATIC MYCOSES IN HOSPITALIZED PATIENTS WITH IVH. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27912 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSES ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27562 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSES ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27926 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSES ASSOCIATED WITH SERIOUS TRAUMA AND BURN |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27556 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSES ASSOCIATED WITH SERIOUS TRAUMA AND BURN |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27920 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN PATIENTS WITH BRAIN TUMOR AND CEREBROVASCULAR DISEASES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27532 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN PATIENTS WITH BRAIN TUMOR AND CEREBROVASCULAR DISEASES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27896 |
